Depression Treatment in Gurugram —
Dr. Anindo Mitra, Consultant Psychiatrist
By Dr. Anindo Mitra | MBBS, MD Psychiatry (JIPMER) | Consultant Psychiatrist, Athena Behavioural Health, Gurugram
Depression is not a character flaw or a response to a difficult week. It is a clinical condition that affects how the brain regulates mood, sleep, concentration, and motivation — and it is one of the most treatable psychiatric conditions when the diagnosis is correct and the treatment plan is honest.
Depression presents differently in different people. Some patients describe persistent low mood and hopelessness. Others lose interest in things they previously found meaningful, or notice that their sleep has shifted — either sleeping far too much or lying awake for hours. Concentration difficulties, fatigue that does not improve with rest, changes in appetite, and a pervasive sense that things will not get better are all part of the clinical picture. In some presentations, irritability is more prominent than sadness — particularly in younger patients and men. In others, physical symptoms dominate: headaches, digestive complaints, body pain that investigations fail to explain.
The first task in any depression consultation is to build an accurate picture of what is actually happening — because the right treatment for depression depends on what kind of depression it is.
What depression actually looks like — and why diagnosis matters before treatment
Depression is not a single condition with a single cause. Several distinct presentations require different clinical approaches, and treating them as identical produces poor outcomes.
Major depressive disorder (MDD) is characterised by persistent low mood or loss of interest lasting at least two weeks, accompanied by changes in sleep, appetite, energy, concentration, and in more severe presentations, thoughts of death or suicide. It can occur as a single episode or recurrently. Recurrent depression — where episodes return after periods of recovery — requires a different long-term management strategy than a first episode, because the threshold for subsequent episodes lowers with each one left untreated.
Bipolar depression is the presentation that most frequently leads to misdiagnosis and inappropriate treatment. A patient in the depressive phase of bipolar disorder looks clinically similar to someone with unipolar MDD — but prescribing an antidepressant without a mood stabiliser in bipolar depression carries a real risk of triggering a manic episode or rapid cycling. Identifying features that suggest bipolarity — a history of periods of elevated mood or unusual energy, a family history of bipolar disorder, an early age of onset, or antidepressants that have previously caused agitation or mood instability — changes the entire treatment plan.
Persistent depressive disorder (dysthymia) involves a chronically low mood that may be less severe than MDD but lasts for two years or more. These patients often describe feeling "always a bit flat" rather than acutely depressed, and they frequently present late because they have normalised the baseline.
Secondary depression refers to depressive symptoms driven by an underlying medical condition or medication. Hypothyroidism, anaemia, vitamin B12 deficiency, and certain medications (including beta-blockers, steroids, and some contraceptives) can all produce a clinical picture that resembles depression. Identifying and addressing the underlying cause changes the treatment entirely.
A thorough first consultation at ManoMitra covers all of these possibilities before any treatment decision is made.
How depression is approached at ManoMitra
The approach at ManoMitra is deliberately unhurried. Depression is not automatically treated with an antidepressant on the first visit.
For mild to moderate presentations, the first-line approach is:
Accurate diagnosis — ruling out bipolar depression, thyroid dysfunction, nutritional deficiencies, and medication-related causes before starting any treatment.
Sleep normalisation — poor sleep both worsens and maintains depression, and addressing it directly is often one of the highest-yield early interventions.
Psychotherapy — specifically Cognitive Behavioural Therapy (CBT) and Interpersonal Therapy (IPT), which have the strongest evidence base for depression. Dr. Mitra helps patients access structured psychotherapy through coordination with clinical psychologists, and integrates psychotherapeutic principles into consultations where appropriate.
Lifestyle and behavioural activation — structured physical activity has effect sizes comparable to antidepressants in mild-to-moderate depression, and the evidence for this is frequently underused in clinical practice.
tDCS (transcranial Direct Current Stimulation) — a non-invasive neuromodulation option available as an at-home device under supervision. For patients who prefer to avoid medication initially, or who cannot tolerate antidepressant side effects, tDCS offers an evidence-based alternative.
When antidepressants are indicated — in moderate-to-severe depression, in recurrent depression, or where psychotherapy alone has not produced sufficient improvement — the choice of medication is individualised. This means considering your symptom profile, sleep pattern, occupational demands, pre-existing conditions, and side effect priorities. Antidepressants that cause significant sedation, sexual dysfunction, or weight gain affect quality of life in ways that are clinically meaningful and are discussed openly before a prescription is written.
Antidepressant decisions also include a plan for duration. Many patients arrive having been on antidepressants for years without a clear clinical rationale for continuing, or without having discussed whether tapering might be appropriate. That conversation is part of every ongoing treatment relationship at ManoMitra.
When to seek help
Many people wait months or years before consulting a psychiatrist for depression — often because they are unsure whether what they are experiencing is "bad enough," or because they expect to manage it without professional support.
The following are clear signals that a psychiatric consultation is appropriate:
Symptoms that have persisted for more than two weeks and are affecting daily functioning — work, relationships, sleep, or basic self-care.
Thoughts of death, suicide, or self-harm — at any level of intensity, these warrant prompt assessment.
A previous episode of depression that has returned.
Antidepressants or other treatments that have not worked, or that have caused intolerable side effects.
Uncertainty about whether a current diagnosis or prescription is correct.
A desire to reduce or stop medication that was started without a clear endpoint.
Frequently asked questions about depression
Is depression a chemical imbalance?
The "chemical imbalance" explanation — specifically the idea that depression is caused by low serotonin — is an oversimplification that does not reflect the current scientific understanding. Depression involves changes in multiple neurotransmitter systems, inflammatory pathways, neuroplasticity, and stress-response circuits. Antidepressants that act on serotonin work for many patients, but not because they "correct" a deficit — the mechanism is more complex and still not fully understood. This does not make depression any less real or any less treatable.
How long does antidepressant treatment last?
For a first episode of depression that responds to treatment, current guidelines generally recommend continuing the antidepressant for at least 6–12 months after symptom resolution before considering a taper. For patients with two or more previous episodes, or with residual symptoms, longer-term maintenance is often appropriate. The decision about duration is individualised and should be actively reviewed — not left open-ended indefinitely.
Can depression come back after treatment?
Yes, and this is clinically important to understand. Around 50% of people who have one depressive episode will have at least one more. After two episodes, the risk of a third rises further. This does not mean treatment has failed — it means depression, in some people, is a recurrent condition that benefits from a longer-term management strategy rather than episodic treatment.
What is the difference between depression and grief?
Grief following a significant loss is a normal human response and does not automatically constitute a depressive disorder. The distinction lies in the persistence, severity, and functional impact of symptoms. Grief typically involves waves of sadness punctuated by positive memories and periods of relative relief; major depression involves a more pervasive and unremitting quality. When grief extends beyond a few months, significantly impairs functioning, or involves features like suicidal ideation or profound hopelessness, a clinical assessment is appropriate.
Are antidepressants addictive?
Antidepressants do not cause addiction in the clinical sense — they do not produce tolerance, craving, or drug-seeking behaviour. However, many antidepressants do cause discontinuation symptoms when stopped abruptly — dizziness, flu-like feelings, sleep disturbance, and mood fluctuations. These are physiological effects of stopping a medication the nervous system has adapted to, not withdrawal from addiction. Tapering gradually, under supervision, minimises these effects significantly.
Is it possible to manage depression without medication?
For mild-to-moderate depression, psychotherapy (particularly CBT and IPT), structured physical activity, sleep normalisation, and neuromodulation (tDCS) can be effective without medication. For moderate-to-severe depression, or depression that has not responded to non-pharmacological approaches, antidepressants significantly improve outcomes and are clinically appropriate. The decision is not medication versus no medication — it is which combination of interventions fits this patient, at this severity, at this stage.
Can a teleconsultation work for depression treatment?
Yes, for the majority of patients managing depression in an outpatient setting. Psychiatric evaluation, antidepressant initiation and monitoring, psychotherapy coordination, and medication review are all well-suited to teleconsultation. If a presentation suggests significant risk — active suicidal ideation with intent, first-episode psychosis, or a need for urgent physical assessment — an in-person evaluation or emergency referral is the appropriate step.